Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1345-1345
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 591-591
Open Access | Times Cited: 65
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
Byungji Kim, Ryan R. Hosn, Tanaka Remba, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 241-253
Open Access | Times Cited: 63
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
Séan Mc Cafferty, A.K.M. Ashiqul Haque, Aster Vandierendonck, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 2968-2983
Open Access | Times Cited: 42
COVID-19: Why Do People Refuse Vaccination? The Role of Social Identities and Conspiracy Beliefs: Evidence from Nationwide Samples of Polish Adults
Marta Marchlewska, Katarzyna Hamer, Maria Baran, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 268-268
Open Access | Times Cited: 40
The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system
Marie‐Clotilde Bernard, Emilie Bazin, Nadine Petiot, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 794-806
Open Access | Times Cited: 29
Antibiotic resistance and tolerance: What can drug delivery do against this global threat?
Juan Aparicio-Blanco, Nikhar Vishwakarma, Claus‐Michael Lehr, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 6, pp. 1725-1734
Open Access | Times Cited: 14
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?
Kyu-Bin Oh, T. Mark Doherty, Volker Vetter, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1541-1553
Open Access | Times Cited: 36
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 6
Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated?
Aniello Maiese, A. Baronti, A Manetti, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 308-308
Open Access | Times Cited: 28
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 28
Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer
Noelia Silva-Pilipich, Aritz Lasarte-Cía, Teresa Lozano, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 387-399
Open Access | Times Cited: 20
Lateral flow immunoassay for rapid and sensitive detection of dsRNA contaminants in in vitro-transcribed mRNA products
Dengwang Luo, Zhanfeng Wu, Daming Wang, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 445-453
Open Access | Times Cited: 12
Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers
Seungkyun Woo, Pil‐Gu Park, Timothy An, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects
Zijing Wei, Shuai Zhang, Xingya Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Development of polypeptide-based materials toward messenger RNA delivery
Bowen Zhao, Xiao Zhang, Molly S. Bickle, et al.
Nanoscale (2023) Vol. 16, Iss. 5, pp. 2250-2264
Closed Access | Times Cited: 10
Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook
Abhishek Verma, Ankit Awasthi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 14, pp. 1049-1059
Closed Access | Times Cited: 3
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
Katharine Valéria Saraiva Hodel, Bianca Sampaio Dotto Fiuza, Rodrigo Souza Conceição, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 807-807
Open Access | Times Cited: 3
Influence of Nanobubble Size Distribution on Ultrasound-Mediated Plasmid DNA and Messenger RNA Gene Delivery
Hiroshi Kida, Loreto B. Feril, Yutaka Irie, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
RNA Combined with Nanoformulation to Advance Therapeutic Technologies
Eduarda Lima, Déborah dos Santos, Atena Liriel Souza, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1634-1634
Open Access | Times Cited: 7
Nanotechnology-Based RNA Vaccines: Fundamentals, Advantages and Challenges
Vitaly P. Pozharov, Tamara Minko
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 194-194
Open Access | Times Cited: 6
Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects
Katharine Valéria Saraiva Hodel, Ananda Fonseca, Islania Almeida Brandão Barbosa, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 13, pp. 1651-1663
Closed Access | Times Cited: 1
An overview on recent patents and technologies on nanoparticles for nucleic acid delivery
Larissa Moraes dos Santos Fonseca, Bruna Aparecida Souza Machado, Fabricia Oliveira Oliveira, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 3, pp. 171-186
Closed Access | Times Cited: 1
Poly(2-oxazoline)/saRNA Polyplexes for Targeted and Nonviral Gene Delivery
Graham Hayes, Beatriz Dias-Barbieri, Gökhan Yilmaz, et al.
Biomacromolecules (2023) Vol. 24, Iss. 11, pp. 5142-5151
Open Access | Times Cited: 3
A Review of Clinical Trials of Cancer and Its Treatment as a Vaccine
Chandni Chandarana, Anuradha Tiwari
Reviews on Recent Clinical Trials (2023) Vol. 19, Iss. 1, pp. 7-33
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top